An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy
2017 · Scientific Reports · 143 citations
https://doi.org/10.1038/s41598-017-11626-x
J
Jennifer Chambers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
1.6K
Citations
16
h-index
18
i10-index
Jennifer Chambers is an academic researcher. The author has contributed to research in topics: Pediatric Hepatobiliary Diseases and Treatments & Drug Transport and Resistance Mechanisms & Pregnancy and Medication Impact. The author has an h-index of 16, co-authored 33 publications.
ORCID: 0000-0001-8491-2514Papers by this author
worksA multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial
2021 · BMC Pregnancy and Childbirth · 43 citations
https://doi.org/10.1186/s12884-020-03481-y
Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy
2020 · Scientific Reports · 25 citations
https://doi.org/10.1038/s41598-020-67301-1
Additional file 1 of A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13565921
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat